This session highlights the vital contributions of associates and advanced practice providers (APPs) in advancing hepatology care through real-world insights, innovative treatment strategies, and impactful quality improvement initiatives. Through data-driven research and patient-centered approaches, these presenters demonstrate the power of associate- and APP-led initiatives to improve outcomes and expand access in diverse clinical settings.
Describe the clinical significance and evolving management strategies for patients with rare cholestatic liver diseases, including insights from prospective registries.
Evaluate strategies to optimize transplant outcomes through better risk stratification and post-transplant behavioral support.
Apply real-world, APP-led interventions to enhance symptom control, improve access to care, and support high-risk populations across hepatology care settings.